Prestige Consumer Healthcare Inc. $PBH Stock Holdings Increased by Kayne Anderson Rudnick Investment Management LLC

Key Points

• Kayne Anderson Rudnick Investment Management LLC increased its stake in Prestige Consumer Healthcare by 45.3% in the first quarter, owning approximately 3.19% of the company, valued at $135.9 million.
• Prestige Consumer Healthcare reported a quarterly revenue decline of 6.6% year-over-year, with earnings per share of $0.95, missing analyst expectations by $0.06.
• Research analysts have a mixed outlook on Prestige Consumer Healthcare, with an average rating of “Moderate Buy” and a target price of $93.33, following recent adjustments in their ratings.

Kayne Anderson Rudnick Investment Management LLC increased its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 45.3% during the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,580,819 shares of the company's stock after purchasing an additional 493,199 shares during the period. Kayne Anderson Rudnick Investment Management LLC owned 3.19% of Prestige Consumer Healthcare worth $135,903,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. GAMMA Investing LLC raised its position in shares of Prestige Consumer Healthcare by 35.9% in the 1st quarter. GAMMA Investing LLC now owns 1,879 shares of the company's stock valued at $162,000 after purchasing an additional 496 shares during the last quarter. KBC Group NV increased its holdings in Prestige Consumer Healthcare by 7.4% in the first quarter. KBC Group NV now owns 2,199 shares of the company's stock valued at $189,000 after buying an additional 151 shares in the last quarter. QRG Capital Management Inc. boosted its stake in shares of Prestige Consumer Healthcare by 8.6% during the 1st quarter. QRG Capital Management Inc. now owns 5,971 shares of the company's stock worth $513,000 after acquiring an additional 475 shares in the last quarter. BNP Paribas Financial Markets increased its position in shares of Prestige Consumer Healthcare by 1,073.3% in the fourth quarter. BNP Paribas Financial Markets now owns 203,903 shares of the company's stock valued at $15,923,000 after buying an additional 186,524 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC raised its position in Prestige Consumer Healthcare by 14.1% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 8,315 shares of the company's stock worth $649,000 after acquiring an additional 1,030 shares during the period. 99.95% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

PBH has been the topic of a number of analyst reports. Canaccord Genuity Group reduced their price objective on Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating on the stock in a research report on Friday, August 8th. Royal Bank Of Canada raised shares of Prestige Consumer Healthcare to a "hold" rating in a research report on Thursday, May 8th. Finally, Wall Street Zen lowered Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Three research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Prestige Consumer Healthcare currently has an average rating of "Moderate Buy" and an average target price of $93.33.

Prestige Consumer Healthcare Stock Performance

Shares of NYSE:PBH traded up $0.41 during trading on Thursday, reaching $67.37. The company had a trading volume of 676,013 shares, compared to its average volume of 397,856. The firm has a market capitalization of $3.32 billion, a price-to-earnings ratio of 15.81, a price-to-earnings-growth ratio of 2.10 and a beta of 0.43. The stock's fifty day moving average price is $74.26 and its 200 day moving average price is $80.83. Prestige Consumer Healthcare Inc. has a fifty-two week low of $62.95 and a fifty-two week high of $90.04. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.38 and a quick ratio of 2.99.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported $0.95 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.01 by ($0.06). The company had revenue of $249.53 million during the quarter, compared to analysts' expectations of $260.71 million. Prestige Consumer Healthcare had a net margin of 19.02% and a return on equity of 12.69%. Prestige Consumer Healthcare's quarterly revenue was down 6.6% compared to the same quarter last year. During the same period in the previous year, the company posted $0.90 EPS. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. As a group, equities research analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.